FDA approval expands Guerbet’s gadopiclenol into neonates, reinforcing half-dose MRI contrast strategies. Find out what this changes for pediatric imaging.
Find out how transcatheter tricuspid valve replacement is reshaping treatment options for severe regurgitation and what clinicians are watching next.
Lake Forest Regenesis launches Emsculpt NEO and Emsella. Discover what this means for noninvasive devices, regulation, and clinical adoption.
GE HealthCare’s FDA-cleared SIGNA MRI systems signal a shift toward autonomous, helium-free imaging. Explore what this means for MRI operations.
Belay Diagnostics validates its Summit 2.0 CSF genomic assay, strengthening the clinical case for liquid biopsy in CNS cancers. Read the full analysis.
Sibel Health secures FDA acceptance for its Aria cough sensor. Find out what this could change for chronic cough drug trials and digital endpoints.
NCCN guidelines now recommend Merlin CP-GEP for early-stage melanoma risk assessment. Discover what this changes for clinicians and diagnostics adoption.
Bimini Health Tech secures FDA clearance for Puregraft SYNC. Explore what it changes for fat grafting workflows, adoption economics, and device strategy.
Explore how BON Natural Life Limited’s bio-electronic apple polyphenol mask could reshape medical aesthetics if clinical data holds up.
Life Spine confirms MR Conditional status for ProLift. Find out why MRI compatibility now defines spine implant viability rather than differentiation.